Predictive Oncology INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Theodore Zhu, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.
Charles Lee Nuzum Sr, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.
Matthew Hawryluk, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.
Daniel E Handley, a Director of Predictive Oncology Inc., received 528 shares of common stock on October 1, 2026.
Thorsten Dirks, a Director of Predictive Oncology Inc., reported multiple transactions in common stock on April 20, 2026.
Clair Gregory St. Sr, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.
Theodore Zhu, a Director of Predictive Oncology Inc., purchased 8,750 shares of common stock on September 8, 2026.
Theodore Zhu, a Director of Predictive Oncology Inc., received 2,420 shares of common stock on July 1, 2026.
Clair Gregory St. Sr, a Director of Predictive Oncology Inc., received 2,420 shares of common stock on July 1, 2026.
Charles Lee Nuzum Sr, a Director of Predictive Oncology Inc., received 2,420 shares of common stock on July 1, 2026.
Matthew Hawryluk, a Director of Predictive Oncology Inc., received 1,716 shares of common stock on July 1, 2026.
Daniel E Handley, a Director of Predictive Oncology Inc., received 1,716 shares of common stock on July 1, 2026.
Axe Compute Inc. officer Joshua Blacher reports a transaction involving restricted stock units.
Director Theodore Zhu acquired 5,144 shares of Axe Compute Inc. common stock as compensation for board service.
Axe Compute Inc. director Charles Lee Nuzum Sr. acquired 14,082 shares of common stock as compensation for board services.
Axe Compute Inc. Director Veena Rao received 4,197 shares of common stock as compensation for board services on March 6, 2026.
Axe Compute Inc. director Shawn Matthews was issued 1,166 shares of common stock as compensation for his board service.
Director Gregory St. Clair Sr. acquired 9,419 shares of Axe Compute Inc. as compensation for board service, increasing his total holdings to 15,146 shares.
Director Matthew Hawryluk acquired 6,782 shares of Axe Compute Inc. as compensation for board service, increasing his total direct ownership to 11,727 shares.
Director Daniel Handley acquired 5,663 shares of Axe Compute Inc. as compensation for board service, bringing his total ownership to 11,040 shares.
Axe Compute Inc. reports the grant of 225,000 stock options to Co-Chief Financial Officer Jeremy Yaukey-Witter as an inducement award.
Axe Compute Inc. reports the grant of 300,000 non-qualified stock options to President Kyle Robert Okamoto.
Axe Compute Inc. CEO Raymond F Vennare's employment was terminated, coinciding with recent RSU transactions and tax withholdings.
Predictive Oncology Inc. CEO Raymond F Vennare reported a disposition of 2,373 common shares withheld for tax purposes following the vesting of restricted stock units.
Predictive Oncology Inc. Director Nancy Chung-Welch was granted 64,680 restricted stock units, vesting fully on October 31, 2025.
Predictive Oncology Inc. Director Daniel E. Handley received a grant of 64,680 restricted stock units, which are set to vest on October 31, 2025.
Predictive Oncology Inc. Director Matthew Hawryluk was granted 64,680 restricted stock units, vesting fully on October 31, 2025.
Predictive Oncology Inc. Director Veena Rao was granted 64,680 restricted stock units, vesting in full on October 31, 2025.
Predictive Oncology Inc. Director Gregory St. Clair received a grant of 64,680 restricted stock units, vesting fully on October 31, 2025.
Predictive Oncology Inc. Director Charles Lee Nuzum Sr. was granted 64,680 restricted stock units, vesting October 31, 2025.